257 related articles for article (PubMed ID: 16955691)
1. Gene therapy and coronary artery bypass grafting: current perspectives.
George SJ; Channon KM; Baker AH
Curr Opin Mol Ther; 2006 Aug; 8(4):288-94. PubMed ID: 16955691
[TBL] [Abstract][Full Text] [Related]
2. Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery.
Baker AH; Yim AP; Wan S
Diabetes Obes Metab; 2006 Mar; 8(2):119-24. PubMed ID: 16448515
[TBL] [Abstract][Full Text] [Related]
3. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
4. What has happened to multiple arterial grafting in coronary artery bypass grafting surgery?
Elghobary T; Légaré JF
Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1099-105. PubMed ID: 20670188
[TBL] [Abstract][Full Text] [Related]
5. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts.
McEnany MT; Salzman EW; Mundth ED; DeSanctis RW; Harthorne JW; Weintraub RM; Gates S; Austen WG
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):81-9. PubMed ID: 7033673
[TBL] [Abstract][Full Text] [Related]
6. The fate of the radial artery conduit in coronary artery bypass grafting surgery.
Nezić DG; Knezević AM; Milojević PS; Dukanović BP; Jović MD; Borzanović MD; Nesković AN
Eur J Cardiothorac Surg; 2006 Aug; 30(2):341-6. PubMed ID: 16829081
[TBL] [Abstract][Full Text] [Related]
7. Intermediate-term patency of saphenous vein graft with a clampless hand-sewn proximal anastomosis device after off-pump coronary bypass grafting.
Shimokawa T; Manabe S; Sawada T; Matsuyama S; Fukui T; Takanashi S
Ann Thorac Surg; 2009 May; 87(5):1416-20. PubMed ID: 19379877
[TBL] [Abstract][Full Text] [Related]
8. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure.
Khaleel MS; Dorheim TA; Duryee MJ; Durbin HE; Bussey WD; Garvin RP; Klassen LW; Thiele GM; Anderson DR
Ann Thorac Surg; 2012 Feb; 93(2):552-8. PubMed ID: 22206954
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
[TBL] [Abstract][Full Text] [Related]
10. [Vascular biology of coronary bypass grafts. Literature review].
Barandon L; Kindo M; Perrault LP; Hebert Y; Cartier R; Bouchard D; Demers P; Pagé P; Carrier M; Pellerin M
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1206-15. PubMed ID: 15669362
[TBL] [Abstract][Full Text] [Related]
11. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage.
Tsui JC; Dashwood MR
Eur J Vasc Endovasc Surg; 2002 Mar; 23(3):202-8. PubMed ID: 11914005
[TBL] [Abstract][Full Text] [Related]
12. [The saphenous vein graft diseases].
Yavuz T; Kutsal A
Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
14. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits.
Hayward PA; Buxton BF
Ann Thorac Surg; 2007 Sep; 84(3):795-9. PubMed ID: 17720377
[TBL] [Abstract][Full Text] [Related]
15. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial.
Desai ND; Naylor CD; Kiss A; Cohen EA; Feder-Elituv R; Miwa S; Radhakrishnan S; Dubbin J; Schwartz L; Fremes SE;
Circulation; 2007 Feb; 115(6):684-91. PubMed ID: 17283268
[TBL] [Abstract][Full Text] [Related]
16. Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.
Glineur D; Hanet C; Poncelet A; D'hoore W; Funken JC; Rubay J; Astarci P; Lacroix V; Verhelst R; Etienne PY; Noirhomme P; El Khoury G
J Thorac Cardiovasc Surg; 2008 Aug; 136(2):482-8. PubMed ID: 18692661
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.
Alexander JH; Hafley G; Harrington RA; Peterson ED; Ferguson TB; Lorenz TJ; Goyal A; Gibson M; Mack MJ; Gennevois D; Califf RM; Kouchoukos NT;
JAMA; 2005 Nov; 294(19):2446-54. PubMed ID: 16287955
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy to prevent occlusion of venous bypass grafts.
Bhardwaj S; Roy H; Ylä-Herttuala S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):641-52. PubMed ID: 18510482
[TBL] [Abstract][Full Text] [Related]
19. The lima success story--whither other arterial grafts--are vein grafts obsolete?
Cooper GJ; Underwood MJ; Deverall PB
Br J Clin Pract; 1996; 50(3):144-50. PubMed ID: 8733333
[TBL] [Abstract][Full Text] [Related]
20. Arterial and venous conduits for coronary artery bypass. A current review.
Cooper GJ; Underwood MJ; Deverall PB
Eur J Cardiothorac Surg; 1996; 10(2):129-40. PubMed ID: 8664004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
